Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2004 Aug;41(8):585–590. doi: 10.1136/jmg.2004.019190

Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China

T Guo 1, F Zhang 1, M Yang 1, X Gao 1, L Bian 1, S Duan 1, Z Zheng 1, J Gao 1, H Wang 1, R Li 1, G Feng 1, C St 1, L He 1
PMCID: PMC1735866  PMID: 15286152

Abstract

Background: Iodine deficiency is the commonest cause of preventable mental retardation (MR) worldwide. However, in iodine-deficient areas not everyone is affected and familial aggregation is common. This suggests that genetic factors may also contribute. Thyroid hormone (TH) plays an important role in fetal and early postnatal brain development. The pro-hormone T4 (3,3',5,5'-triiodothyronine) is converted in the brain to its active form, T3, or its inactive metabolite, reverse T3, mainly by the action of deiodinase type 2 (DIO2).

Methods: To investigate the potential genetic contribution of the DIO2 gene, we performed a case-control association study using three common SNPs in the gene (rs225014, rs225012, and rs225010) that were in strong linkage disequilibrium with each other.

Results: Single marker analysis showed a positive association of MR with rs225012 and rs225010. Particularly with rs225012, TT genotype frequency was significantly higher in MR cases than in controls (χ2 = 9.18, p = 0.00246). When we compared the distributions of common haplotypes, we also found significant differences between mental retardation and controls in the haplotype combination of rs225012 and rs225010 (χ2 = 15.04, df 2, global p = 0.000549). This association remained significant after Bonferroni correction (p = 0.0016470).

Conclusion: We conclude that allelic variation in the DIO2 gene may affect the amount of T3 available and in an iodine-deficient environment may partly determine overall risk of MR.

Full Text

The Full Text of this article is available as a PDF (100.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buettner C., Harney J. W., Larsen P. R. The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Endocrinology. 2000 Dec;141(12):4606–4612. doi: 10.1210/endo.141.12.7831. [DOI] [PubMed] [Google Scholar]
  2. Celi F. S., Canettieri G., Yarnall D. P., Burns D. K., Andreoli M., Shuldiner A. R., Centanni M. Genomic characterization of the coding region of the human type II 5'-deiodinase gene. Mol Cell Endocrinol. 1998 Jun 25;141(1-2):49–52. doi: 10.1016/s0303-7207(98)00093-8. [DOI] [PubMed] [Google Scholar]
  3. Croteau W., Davey J. C., Galton V. A., St Germain D. L. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest. 1996 Jul 15;98(2):405–417. doi: 10.1172/JCI118806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Germer S., Holland M. J., Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 2000 Feb;10(2):258–266. doi: 10.1101/gr.10.2.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Köhrle J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol Cell Endocrinol. 1999 May 25;151(1-2):103–119. doi: 10.1016/s0303-7207(99)00040-4. [DOI] [PubMed] [Google Scholar]
  6. Li W. W., Le Goascogne C., Schumacher M., Pierre M., Courtin F. Type 2 deiodinase in the peripheral nervous system: induction in the sciatic nerve after injury. Neuroscience. 2001;107(3):507–518. doi: 10.1016/s0306-4522(01)00362-1. [DOI] [PubMed] [Google Scholar]
  7. Mallat M., Lima F. R. S., Gervais A., Colin C., Moura Neto V. New insights into the role of thyroid hormone in the CNS: the microglial track. Mol Psychiatry. 2002;7(1):7–8. doi: 10.1038/sj.mp.4000988. [DOI] [PubMed] [Google Scholar]
  8. Mentuccia Daniela, Proietti-Pannunzi Laura, Tanner Keith, Bacci Vincenzo, Pollin Toni I., Poehlman Eric T., Shuldiner Alan R., Celi Francesco S. Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes. 2002 Mar;51(3):880–883. doi: 10.2337/diabetes.51.3.880. [DOI] [PubMed] [Google Scholar]
  9. Paschke R., Ludgate M. The thyrotropin receptor in thyroid diseases. N Engl J Med. 1997 Dec 4;337(23):1675–1681. doi: 10.1056/NEJM199712043372307. [DOI] [PubMed] [Google Scholar]
  10. Perneger T. V. What's wrong with Bonferroni adjustments. BMJ. 1998 Apr 18;316(7139):1236–1238. doi: 10.1136/bmj.316.7139.1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pertea M., Lin X., Salzberg S. L. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res. 2001 Mar 1;29(5):1185–1190. doi: 10.1093/nar/29.5.1185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Salvatore D., Low S. C., Berry M., Maia A. L., Harney J. W., Croteau W., St Germain D. L., Larsen P. R. Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. J Clin Invest. 1995 Nov;96(5):2421–2430. doi: 10.1172/JCI118299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sasieni P. D. From genotypes to genes: doubling the sample size. Biometrics. 1997 Dec;53(4):1253–1261. [PubMed] [Google Scholar]
  14. Schneider M. J., Fiering S. N., Pallud S. E., Parlow A. F., St Germain D. L., Galton V. A. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol. 2001 Dec;15(12):2137–2148. doi: 10.1210/mend.15.12.0740. [DOI] [PubMed] [Google Scholar]
  15. Sham P. C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet. 1995 Jan;59(Pt 1):97–105. doi: 10.1111/j.1469-1809.1995.tb01608.x. [DOI] [PubMed] [Google Scholar]
  16. Sherrington R., Rogaev E. I., Liang Y., Rogaeva E. A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995 Jun 29;375(6534):754–760. doi: 10.1038/375754a0. [DOI] [PubMed] [Google Scholar]
  17. Stephens M., Smith N. J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001 Mar 9;68(4):978–989. doi: 10.1086/319501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wang H. Y., Zhang F. C., Gao J. J., Fan J. B., Liu P., Zheng Z. J., Xi H., Sun Y., Gao X. C., Huang T. Z. Apolipoprotein E is a genetic risk factor for fetal iodine deficiency disorder in China. Mol Psychiatry. 2000 Jul;5(4):363–368. doi: 10.1038/sj.mp.4000735. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Erratum]
jmedgene_41_8_585__index.html (1.2KB, html)

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES